We propose to continue to isolate and characterize """"""""tumor host range"""""""" (THR) mutants of polyoma virus in efforts to identify and characterize the cellular targets of the viral T (tumor) antigens. The rationale behind this selection is that tumor cells may have undergone the loss of particular function(s) which the wild type virus normally targets. These functions may represent tumor suppressor genes or other regulators of replication and survival which the virus needs to inactivate or alter in some manner in order to replicate efficiently. THR mutants are selected to be able to grow on certain tumor cells but not on normal cells and are presumed to have lost the targeting function. One THR mutants has been used to identify the multi-zinc finger homeotic transcription factor Sal2 as a target of the polyoma large T antigen. We have shown that Sal2 acts in some important respects like p53 in terms of its growth arrest and apoptosis inducing properties. In this application we focus on Sal2 with efforts to determine its downstream cellular gene targets, upstream regulators and protein partners. Expression profiling analysis and chromatin immunoprecipitation (ChIP) will be used in these investigations. We will also seek to determine the mutual effects which large T and Sal2 exert on each other based on their interaction. Sal2 is highly expressed in ovarian surface epithelial cells. Preliminary evidence indicates that Sal2 expression is lost in human ovarian carcinomas. We propose to examine further if such loss occurs and at what frequency in various forms of ovarian carcinoma. We will test the hypothesis that promoter methylation in one of the two alternative Sal2 promoters may account for Sal2 silencing in some cases of ovarian carcinoma. Finally, we will take several approaches to developing a mouse model of ovarian cancer based on recent findings on the large T-Sal2 interaction and on the isolation of a new strain of polyoma which efficiently induces ovarian surface epithelial tumors in certain strains of mice. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA092520-08
Application #
7471532
Study Section
Virology - B Study Section (VIRB)
Program Officer
Blair, Donald G
Project Start
2001-09-01
Project End
2011-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
8
Fiscal Year
2008
Total Cost
$617,981
Indirect Cost
Name
Harvard University
Department
Pathology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Sung, Chang Kyoo; Yim, Hyungshin; Andrews, Erik et al. (2014) A mouse polyomavirus-encoded microRNA targets the cellular apoptosis pathway through Smad2 inhibition. Virology 468-470:57-62
Sung, Chang K; Li, Dawei; Andrews, Erik et al. (2013) Promoter methylation of the SALL2 tumor suppressor gene in ovarian cancers. Mol Oncol 7:419-27
Sung, Chang Kyoo; Yim, Hyungshin; Gu, Hongcang et al. (2012) The polyoma virus large T binding protein p150 is a transcriptional repressor of c-MYC. PLoS One 7:e46486
Yang, Ying; Jiang, Beibei; Huo, Yingqing et al. (2011) Shp2 suppresses PyMT-induced transformation in mouse fibroblasts by inhibiting Stat3 activity. Virology 409:204-10
Gu, Hongcang; Li, Dawei; Sung, Chang K et al. (2011) DNA-binding and regulatory properties of the transcription factor and putative tumor suppressor p150(Sal2). Biochim Biophys Acta 1809:276-83
Yim, Hyungshin; Sung, Chang K; You, John et al. (2011) Nek1 and TAZ interact to maintain normal levels of polycystin 2. J Am Soc Nephrol 22:832-7
Sung, Chang K; Dahl, Jean; Yim, Hyungshin et al. (2011) Transcriptional and post-translational regulation of the quiescence factor and putative tumor suppressor p150(Sal2). FASEB J 25:1275-83
Tian, Yu; Kolb, Robert; Hong, Jeong-Ho et al. (2007) TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex. Mol Cell Biol 27:6383-95
Tian, Yu; Li, Dawei; Dahl, Jean et al. (2004) Identification of TAZ as a binding partner of the polyomavirus T antigens. J Virol 78:12657-64
Li, Dawei; Tian, Yu; Ma, Yupo et al. (2004) p150(Sal2) is a p53-independent regulator of p21(WAF1/CIP). Mol Cell Biol 24:3885-93